Advanced kidney cancer "immune and targeted" first-line treatment! The Opdivo-Cabometyx program was approved by the FDA and beats Sutt!
New medicine for rare lung disease! Roche Esbriet (pyridone) is reviewed by the FDA as a priority
Circulation enterprises change bureau 510,000 armed enterprises face a large number of elimination!
First lupus nephritis (LN) oral drug! Lupkynis, the best-in-class calcium-adjusted neurophosphatase inhibitor, has been approved by the FDA!
Step Pharmaceuticals set up a number of subsidiaries will transform scientific research
The combination of the two immunotherapy combinations of Shishi Shiguibao has been approved by the FDA
Fda approves additional treatments for haemophilia and inhibitors of type A or B in adults and adolescents
Sovantini was awarded two fast-track qualifications by the FDA
New drug for cystic fibrosis (CF)! Vertex triple therapy Trikafta has been given FDA priority review to expand the population (6-11 years old)!
Lilly Tauvaid (Flortaucipir F18) is approved by the FDA
Treatment of rosacea The FDA approved the first local therapy for minotin
FDA approves Fiasp to treat diabetes in children
New Alzheimer's (AD) drug! The review period of β protein antibody aducanumab was extended by 3 months by the FDA!